CoAxia (Maple Gove, MN) a clinical-stage medical device company focused on catheter-based therapy for the treatment of cerebral ischemia, closed a $21.5M Series D financing. Participants include Sofinnova Partners, Affinity Capital Management, Baird Venture Partners, Canaan Ventures Partners, Johnson and Johnson Development Corp. and Prism VentureWorks.